ArticleLancet regional health. Americas2026

Person-centered choice and mHealth support for same-day delivery of long-acting injectable cabotegravir (ImPrEP CAB Brasil): a prospective, open-label, multicenter, quasi-experimental implementation study.

Thiago Silva Torres et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.